Ann: Positive Preliminary Results from Adult Clinical Study-RAP.AX, page-182

@rony18 the volume dying is great bc it demonstrates that all the 'sell the news' traders are out & now it has settled down.

The media coverage, GC presentation & other Ann's due this month (US Hospital Partner & a possible WHO update) will generate significant further interest.

RAP became unbelievably de-risked this morning... it's time for LTers to sit back & watch the rise to $1 & beyond over the next little period.

Monetisation is now no longer a risk due to the fact that the clinical risk is now non-existent & they have FDA consultants with 99.9% approval rates guiding them through the FDA red tape.